Purdue Pharma

How McKinsey consultants helped push opioid sales

The New York Times takes a step back from the lawsuits and criminal charges against opioid manufacturers to note that McKinsey, the consulting firm, also keeps coming up in those proceedings.

The big picture: Purdue Pharma and Johnson & Johnson both hired McKinsey to boost opioid sales. McKinsey hasn't been charged or sued for any role in the crisis, but details about the company's involvement have nevertheless crept out through testimony and court filings.

Purdue Pharma's business is struggling amid opioid lawsuits

Purdue Pharma, the maker of OxyContin, is facing sluggish sales, a dwindling workforce and restructuring challenges as it fights a slew of lawsuits claiming that the company contributed to the opioid epidemic, the Wall Street Journal reports.

What's happening: The company's revenue is expected to be less than $1 billion this year for the first time in a decade, and it has said it's considering filing for bankruptcy.